MSL on-demand

Top line data: Upadacitinib in Ulcerative colitis

Keynote speaker: Dr Réme Mountifield
Chair: Prof. Paul Bird 

Topics discussed:
Benefit-risk profile of upadacitinib for the treatment of ulcerative colitis followed by a cross-disciplinary discussion.

Chapters

The views and opinions expressed are those of the individual speaker/speakers and not necessarily those of AbbVie. AbbVie does not endorse the use of unregistered products or products outside of their registered indications. Please refer to the Approved Product Information for licensed instructions. This information is provided to address your specific enquiry and is for your personal reference only. Please note that AbbVie only recommends the use of its products in accordance with the Approved Product Information or Data Sheet.

Have a question for your Medical Science Liaison?  

Divya Mehra Divya Mehra

Rosita Harker
(QLD/NSW/ACT)
Medical Science Liaison
Email: [email protected]
Ph: 0407 703 838

Adrian Tong

Adrian Tong, PhD
(VIC/SA/WA/TAS)
Medical Science Liaison
Email: [email protected]
Ph: 0434 676 102

Esme Shepherd

Esme Shepherd 
(VIC/TAS/SA/WA/NT)
Medical Science Liaison
Email:[email protected]
Ph: 0466 649 354

Reda Hamdi

Reda Hamdi
(NSW/QLD/ACT)
Medical Science Liaison
Email: [email protected]
Ph: 0412 792 868

Francis Shand

Francis Shand, PhD
 (VIC/TAS/SA/WA)
Medical Science Liaison
Email: [email protected]
Ph: 0435 100 042

Mali Ghadiri

Mali Ghadiri, PharmD, PhD
(NSW/ACT/QLD)
Medical Science Liaison
Email: [email protected]
Ph: 0422 991 452

This communication is intended for a healthcare professional audience only and may also contain information that is proprietary, confidential, or exempt from disclosure. Please do not distribute this email, attachment, or any associated content. If you are not the intended recipient, please note that any other dissemination, distribution, use or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer.

ABBV-AU-00081-MC October 2022

Copyright © 2022 AbbVie Pty Ltd. Mascot NSW 2020 Australia.

Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates.
No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.